首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1378760

2023-2028 年按產品與服務、技術（免疫組織化學、聚合酶連鎖反應、原位雜合技術、即時 PCR、基因定序等）、適應症、最終用戶和地區分類的伴隨診斷市場報告

Companion Diagnostics Market Report by Product & Service, Technology (Immunohistochemistry, Polymerase Chain Reaction, In-situ Hybridization, Real-time PCR, Gene Sequencing, and Others), Indication, End User, and Region 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年全球伴隨診斷市場規模達59億美元。展望未來， IMARC Group預計到2028年市場規模將達到133億美元，2022-2028年複合年成長率（CAGR）為14.5%。癌症盛行率的不斷上升、對個人化醫療的需求激增以及下一代定序（NGS）等持續的技術進步是推動市場發展的一些關鍵因素。

伴隨診斷是幫助醫生確定最有效的治療計劃的醫學測試。這些測試旨在識別患者組織或血液樣本中的特定生物標記物，表明患者是否可能從特定藥物或療法中受益。他們還分析患者的詳細生物學特徵和作用機制 (MOA)，並協助醫療專業人員了解藥物的潛在副作用。伴隨診斷廣泛應用於個人化藥物，因為它考慮每個患者的獨特特徵，例如他們的基因組成，以確定最佳的治療計劃。除此之外，它們也擴大用於測試癌症患者的特定基因突變或丙型肝炎患者的生物標記。這有助於醫生針對個別患者制定治療方案，提高成功結果的可能性並降低副作用的風險。

伴隨診斷市場趨勢：

全球各種癌症病例的增加推動了對更有效和更有針對性的癌症治療的需求，這主要推動了市場的成長。伴隨診斷有助於識別最有可能從特定癌症治療中受益的患者，從而獲得更好的患者治療結果。此外，針對每位患者獨特特徵的個人化藥物需求不斷成長，正在為市場創造良好的前景。同時，用於治療多種感染、心血管、神經和發炎疾病的標靶藥物和療法的廣泛採用是另一個重要的生長誘導因素。除此之外，隨著越來越多的測試獲得美國食品和藥物管理局 (US FDA) 等管理機構的批准，以及世界各地不斷增加的臨床試驗數量，伴隨診斷的有利監管環境正在加強市場成長。此外，診斷技術的不斷進步，例如下一代定序（NGS）和液體活體組織切片的出現，可以識別以前難以檢測的生物標記，也有助於市場的成長。除此之外，創新基因組技術的發展使得能夠識別基因突變和其他可用於指導治療決策的生物標記，正在推動市場成長。其他因素，例如在藥物開發中生物標記物的使用不斷增加、對精準醫療的廣泛投資以及消費者對伴隨診斷的好處的認知不斷提高，都為市場帶來了有利可圖的成長機會。

本報告回答的關鍵問題

2022 年全球伴隨診斷市場規模有多大？
2023-2028年全球伴隨診斷市場的預期成長率是多少？
COVID-19 對全球伴隨診斷市場有何影響？
推動全球伴隨診斷市場的關鍵因素是什麼？
基於產品和服務的全球伴隨診斷市場的細分是什麼？
基於該技術的全球伴隨診斷市場的詳細情形如何？
根據該指標，全球伴隨診斷市場的細分如何？
基於最終用戶的全球伴隨診斷市場的詳細情形如何？
全球伴隨診斷市場的關鍵區域有哪些？
全球伴隨診斷市場的主要參與者/公司有哪些？

免疫組織化學 (IHC)
- 市場走向
- 市場預測
聚合酶鍊式反應 (PCR)
- 市場走向
- 市場預測
原位雜合技術 (ISH)
- 市場走向
- 市場預測
即時螢光定量PCR (RT-PCR)
- 市場走向
- 市場預測
基因定序
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 8 章：按跡象分類的市場

癌症
- 市場走向
- 主要類型
  - 肺癌
  - 乳癌
  - 大腸直腸癌
  - 胃癌
  - 黑色素瘤
  - 其他
- 市場預測
神經系統疾病
- 市場走向
- 市場預測
傳染性疾病
- 市場走向
- 市場預測
心血管疾病
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 9 章：最終用戶的市場區隔

製藥及生物製藥公司
- 市場走向
- 市場預測
參考實驗室
- 市場走向
- 市場預測
合約研究組織
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 10 章：按地區分類的市場細分

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太地區
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- Agilent Technologies
- BioMerieux
- Danaher Corporation
- Roche Holding AG
- Myriad Genetics Inc.
- Siemens Healthcare
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112023A2548

Abstract

The global companion diagnostics market size reached US$ 5.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 14.5% during 2022-2028. The increasing prevalence of cancer, the surging demand for personalized medicine, and ongoing technological advancements, such as next-generation sequencing (NGS), represent some of the key factors driving the market.

Companion diagnostics are medical tests that help physicians determine the most effective treatment plan. These tests are designed to identify specific biomarkers in a patient's tissue or blood sample, indicating whether the patient will likely benefit from a particular drug or therapy. They also analyze the detailed biological profile and the mechanism of action (MOA) of patients and assist medical professionals in understanding the potential side effects of medications. Companion diagnostics are widely used across personalized medicines as it considers each patient's unique characteristics, such as their genetic makeup, to determine the best treatment plan. In addition to this, they are increasingly used for testing specific genetic mutations in cancer patients or biomarkers in patients with hepatitis C. This helps physicians tailor treatments to individual patients, improving the likelihood of successful outcomes and reducing the risk of side effects.

Companion Diagnostics Market Trends:

The rising instances of various kinds of cancer across the globe are impelling the demand for more effective and targeted cancer treatments, which is primarily driving the market growth. Companion diagnostics help identify patients who are most likely to benefit from specific cancer therapies, resulting in better patient outcomes. Moreover, the growing demand for personalized medicines tailored to each patient's unique characteristics is creating a favorable outlook for the market. Concurrent with this, the widespread adoption of targeted drugs and therapies for treating numerous infectious, cardiovascular, neurological, and inflammatory conditions is acting as another significant growth-inducing factor. In addition to this, the favorable regulatory landscape for companion diagnostics, with an increasing number of tests receiving approval from governing authorities such as the United States Food and Drug Administration (US FDA), and the expanding number of clinical trials around the world are strengthening the market growth. Furthermore, ongoing advancements in diagnostic technologies, such as the emergence of next-generation sequencing (NGS) and liquid biopsy, which have allowed identifying biomarkers that were formerly difficult to detect, are contributing to the market growth. Besides this, the development of innovative genomic technologies, which have enabled the identification of genetic mutations and other biomarkers that can be used to guide treatment decisions, is fueling the market growth. Other factors, such as the rising use of biomarkers in drug development, extensive investments in precision medicine, and the escalating consumer awareness regarding the benefits of companion diagnostics, are presenting remunerative growth opportunities for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global companion diagnostics market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product & service, technology, indication, and end user.

Product & Service Insights:

Assays, Kits and Reagents

Software and Services

The report has provided a detailed breakup and analysis of the companion diagnostics market based on the product & service. This includes assays, kits and reagents, and software and services. According to the report, assays, kits, and reagents represented the largest segment.

Technology Insights:

Immunohistochemistry (IHC)

Polymerase Chain Reaction (PCR)

In-situ Hybridization (ISH)

Real-time PCR (RT-PCR)

Gene Sequencing

Others

A detailed breakup and analysis of the companion diagnostics market based on technology has also been provided in the report. This includes immunohistochemistry (IHC), polymerase chain reaction (PCR), in-situ hybridization (ISH), real-time PCR (RT-PCR), gene sequencing, and others. According to the report, polymerase chain reaction (PCR) accounted for the largest market share.

Indication Insights:

Cancer

Lung Cancer

Breast Cancer

Colorectal Cancer

Gastric Cancer

Melanoma

Others

Neurological Diseases

Infectious Diseases

Cardiovascular Diseases

Others

The report has provided a detailed breakup and analysis of the companion diagnostics market based on the indication. This includes cancer (lung cancer, breast cancer, colorectal cancer, gastric cancer, melanoma, and others), neurological diseases, infectious diseases, cardiovascular diseases, and others. According to the report, cancer represented the largest segment.

End User Insights:

Pharmaceutical & Biopharmaceutical Companies

Reference Laboratories

Contract Research Organizations

Others

A detailed breakup and analysis of the companion diagnostics market based on the end user has also been provided in the report. This includes pharmaceutical & biopharmaceutical companies, reference laboratories, contract research organizations, and others. According to the report, pharmaceutical & biopharmaceutical companies accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for companion diagnostics. Some of the factors driving the North America companion diagnostics market included the growing prevalence of cancer, the rising adoption of personalized medicines and targeted therapies, and significant advancements in next-generation sequencing (NGS).

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global companion diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Agilent Technologies, BioMerieux, Danaher Corporation, Roche Holding AG, Myriad Genetics Inc., Siemens Healthcare, and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. What was the size of the global companion diagnostics market in 2022?
2. What is the expected growth rate of the global companion diagnostics market during 2023-2028?
3. What has been the impact of COVID-19 on the global companion diagnostics market?
4. What are the key factors driving the global companion diagnostics market?
5. What is the breakup of the global companion diagnostics market based on the product & service?
6. What is the breakup of the global companion diagnostics market based on the technology?
7. What is the breakup of the global companion diagnostics market based on the indication?
8. What is the breakup of the global companion diagnostics market based on the end user?
9. What are the key regions in the global companion diagnostics market?
10. Who are the key players/companies in the global companion diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Companion Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product & Service

6.1 Assays, Kits and Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Software and Services
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Technology

7.1 Immunohistochemistry (IHC)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Polymerase Chain Reaction (PCR)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 In-situ Hybridization (ISH)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Real-time PCR (RT-PCR)
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Gene Sequencing
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Indication

8.1 Cancer
- 8.1.1 Market Trends
- 8.1.2 Major Types
  - 8.1.2.1 Lung Cancer
  - 8.1.2.2 Breast Cancer
  - 8.1.2.3 Colorectal Cancer
  - 8.1.2.4 Gastric Cancer
  - 8.1.2.5 Melanoma
  - 8.1.2.6 Others
- 8.1.3 Market Forecast
8.2 Neurological Diseases
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Infectious Diseases
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Cardiovascular Diseases
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End User

9.1 Pharmaceutical & Biopharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Reference Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Contract Research Organizations
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Agilent Technologies
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 BioMerieux
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Danaher Corporation
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Roche Holding AG
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 SWOT Analysis
- 15.3.6 Myriad Genetics Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Siemens Healthcare
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Thermo Fisher Scientific Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Companion Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Companion Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Companion Diagnostics Market: Breakup by Product & Service (in %), 2022
Figure 4: Global: Companion Diagnostics Market: Breakup by Technology (in %), 2022
Figure 5: Global: Companion Diagnostics Market: Breakup by Indication (in %), 2022
Figure 6: Global: Companion Diagnostics Market: Breakup by End User (in %), 2022
Figure 7: Global: Companion Diagnostics Market: Breakup by Region (in %), 2022
Figure 8: Global: Companion Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Companion Diagnostics (Assays, Kits and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Companion Diagnostics (Assays, Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Companion Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Companion Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Companion Diagnostics (Immunohistochemistry) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Companion Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Companion Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Companion Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Companion Diagnostics (In-situ Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Companion Diagnostics (In-situ Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Companion Diagnostics (Real-time PCR) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Companion Diagnostics (Real-time PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Companion Diagnostics (Gene Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Companion Diagnostics (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Companion Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Companion Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Companion Diagnostics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Companion Diagnostics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Companion Diagnostics (Neurological Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Companion Diagnostics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Companion Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Companion Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Companion Diagnostics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Companion Diagnostics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Companion Diagnostics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Companion Diagnostics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Companion Diagnostics (Pharmaceutical & Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Companion Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Companion Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Companion Diagnostics (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Companion Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Companion Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Companion Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: North America: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: North America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: United States: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: United States: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Canada: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Canada: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Asia Pacific: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Asia Pacific: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: China: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: China: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Japan: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Japan: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: India: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: India: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: South Korea: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: South Korea: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Australia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Australia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Indonesia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Indonesia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Europe: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Europe: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Germany: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Germany: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: France: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: France: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: United Kingdom: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: United Kingdom: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Italy: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Italy: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Spain: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Spain: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Russia: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Russia: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Latin America: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Latin America: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Brazil: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Brazil: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Mexico: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Mexico: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Middle East and Africa: Companion Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Middle East and Africa: Companion Diagnostics Market: Breakup by Country (in %), 2022
Figure 91: Middle East and Africa: Companion Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Companion Diagnostics Industry: SWOT Analysis
Figure 93: Global: Companion Diagnostics Industry: Value Chain Analysis
Figure 94: Global: Companion Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Companion Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Companion Diagnostics Market Forecast: Breakup by Product & Service (in Million US$), 2023-2028
Table 3: Global: Companion Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Companion Diagnostics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 5: Global: Companion Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Companion Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Companion Diagnostics Market Structure
Table 8: Global: Companion Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219